Edesa Biotech Inc. (EDSA) Financial Statements (2024 and earlier)

Company Profile

Business Address 100 SPY COURT
MARKHAM, ON L3R 5H6
State of Incorp. BC
Fiscal Year End September 30
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

3/31/2024
Q2
12/31/2023
Q1
9/30/2023
Q4
6/30/2023
Q3
3/31/2023
Q2
12/31/2022
Q1
9/30/2022
Q4
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments  5,4006,4577,4718,2707,091
Cash and cash equivalents  5,4006,4577,4718,2707,091
Other undisclosed current assets5,4161,0374576588162,001
Total current assets:5,4166,4376,9148,1309,0879,092
Noncurrent Assets
Operating lease, right-of-use asset759111212814718
Property, plant and equipment8910111213
Intangible assets, net (including goodwill)2,1552,1802,2052,2312,2562,281
Intangible assets, net (excluding goodwill)2,1552,1802,2052,2312,2562,281
Deposits noncurrent assets178173    
Other undisclosed noncurrent assets   178174174171
Total noncurrent assets:2,4162,4542,5052,5442,5882,484
TOTAL ASSETS:7,8328,8909,42010,67311,67511,576
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:1,9091,7471,4541,4991,2102,122
Accrued liabilities 1515   22
Other undisclosed accounts payable and accrued liabilities1,8941,7321,4541,4991,2102,100
Other undisclosed current liabilities787575657019
Total current liabilities:1,9871,8221,5291,5651,2802,141
Noncurrent Liabilities
Long-term debt and lease obligation      44
Long-term debt, excluding current maturities      44
Liabilities, other than long-term debt  2040109121 
Accounts payable and accrued liabilities    4444 
Operating lease, liability  20406477 
Total noncurrent liabilities:  204010912144
Total liabilities:1,9871,8421,5691,6741,4012,184
Equity
Equity, attributable to parent, including:5,8457,0497,8509,00010,2739,391
Common stock46,934 46,14145,45444,474 
Additional paid in capital13,22413,03912,59812,49012,41811,176
Accumulated other comprehensive loss(215)(215)(190)(230)(239)(214)
Accumulated deficit(54,097)(52,419)(50,699)(48,714)(46,379)(44,045)
Other undisclosed equity, attributable to parent  46,643   42,473
Total equity:5,8457,0497,8509,00010,2739,391
TOTAL LIABILITIES AND EQUITY:7,8328,8909,42010,67311,67511,576

Income Statement (P&L) ($ in thousands)

3/31/2024
Q2
12/31/2023
Q1
9/30/2023
Q4
6/30/2023
Q3
3/31/2023
Q2
12/31/2022
Q1
9/30/2022
Q4
Revenues      780
Cost of revenue
(Deferred Sales Inducement Cost, Amortization Expense)
     (30) 
Other undisclosed gross profit      760
Gross profit:     (30)1,540
Operating expenses(1,857)(2,370)(2,064)(2,411)(2,378)(2,836)
Other undisclosed operating income (loss)     30(1,540)
Operating loss:(1,857)(2,370)(2,064)(2,411)(2,378)(2,836)
Nonoperating income (expense)179649797743(821)
Loss from continuing operations before equity method investments, income taxes:(1,678)(1,720)(1,985)(2,334)(2,335)(3,658)
Other undisclosed income from continuing operations before income taxes      844
Loss from continuing operations before income taxes:(1,678)(1,720)(1,985)(2,334)(2,335)(2,814)
Income tax expense   (1)  
Loss from continuing operations:(1,678)(1,720)(1,985)(2,334)(2,335)(2,814)
Loss before gain (loss) on sale of properties:(2,814)
Other undisclosed net income  16,749   35,098
Net income (loss):(1,678)15,028(1,985)(2,334)(2,335)32,284
Other undisclosed net loss attributable to parent  (16,749)   (35,098)
Net loss available to common stockholders, diluted:(1,678)(1,720)(1,985)(2,334)(2,335)(2,814)

Comprehensive Income ($ in thousands)

3/31/2024
Q2
12/31/2023
Q1
9/30/2023
Q4
6/30/2023
Q3
3/31/2023
Q2
12/31/2022
Q1
9/30/2022
Q4
Net income (loss):(1,678)15,028(1,985)(2,334)(2,335)32,284
Other comprehensive loss(1,679)     
Other undisclosed comprehensive loss      (17,557)
Comprehensive income (loss):(3,357)15,028(1,985)(2,334)(2,335)14,727
Other undisclosed comprehensive income (loss), net of tax, attributable to parent1,678(16,773)409(25)(17,628)
Comprehensive loss, net of tax, attributable to parent:(1,679)(1,745)(1,945)(2,326)(2,360)(2,902)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: